Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiba Alogheli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Computer-Aided Molecular Design|January 23, 2020
Conformational analysis of macrocycles: comparing general and specialized methodsGustav Olanders, Hiba Alogheli, Peter Brandt, et al.
Journal of Chemical Information and Modeling|January 13, 2017
Docking of Macrocycles: Comparing Rigid and Flexible Docking in GlideHiba Alogheli, Gustav Olanders, Wesley Schaal, et al.
The Journal of Biological Chemistry|April 25, 2013
A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutationAdam F Odell, Luke R Odell, Jon M Askham, et al.
European Journal of Medicinal Chemistry|February 25, 2018
Pan-NS3 protease inhibitors of hepatitis C virus based on an R<sup>3</sup>-elongated pyrazinone scaffoldAnna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocyclesAnna Lampa, Hiba Alogheli, Angelica E Ehrenberg, et al.
Journal of Medicinal Chemistry|March 23, 2013
Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocketJohan Gising, Anna Karin Belfrage, Hiba Alogheli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' RegionAnna K Lampa, Sara M Bergman, Sofia S Gustafsson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Computer-Aided Molecular Design|January 23, 2020
Conformational analysis of macrocycles: comparing general and specialized methodsGustav Olanders, Hiba Alogheli, Peter Brandt, et al.
Journal of Chemical Information and Modeling|January 13, 2017
Docking of Macrocycles: Comparing Rigid and Flexible Docking in GlideHiba Alogheli, Gustav Olanders, Wesley Schaal, et al.
The Journal of Biological Chemistry|April 25, 2013
A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutationAdam F Odell, Luke R Odell, Jon M Askham, et al.
European Journal of Medicinal Chemistry|February 25, 2018
Pan-NS3 protease inhibitors of hepatitis C virus based on an R<sup>3</sup>-elongated pyrazinone scaffoldAnna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocyclesAnna Lampa, Hiba Alogheli, Angelica E Ehrenberg, et al.
Journal of Medicinal Chemistry|March 23, 2013
Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocketJohan Gising, Anna Karin Belfrage, Hiba Alogheli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' RegionAnna K Lampa, Sara M Bergman, Sofia S Gustafsson, et al.
Pageof 1